公司资料
Amylyx 股价、新闻与催化剂
- 股票代码:
- AMLX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
21.43 USD (-0.92%)
收盘价
最后更新: 2026年8月17日
1.48B USD
市值
股价为何变动
As of Aug 17, 2026, AMLX closed down 0.92% at $21.43. No new same-company headline was identified in the current news window.
公司概览
业务概览
Amylyx is a neuroscience company that has shifted after Relyvrio toward a broader rare-disease and neurodegeneration pipeline.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Amylyx sits in specialty neuroscience biotech.
商业模式特征
The company now depends on pipeline execution, data credibility, and rebuilding investor confidence after a major product reset.
生物医药行业定位
Amylyx remains a headline-sensitive CNS name because the market is still reassessing its long-term story.
未来催化剂
- Amylyx's catalysts are AMX0114 and the post-Relyvrio pipeline reset, which need to show the company still has a credible neuroscience path. The next update matters because the story is still being rebuilt.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。